Application of routine electronic health record databases for pharmacogenetic research

A. Yasmina, V. H M Deneer, A. H. Maitland-van der Zee, T. P. van Staa, A. de Boer, O. H. Klungel

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Inter-individual variability in drug responses is a common problem in pharmacotherapy. Several factors (non-genetic and genetic) influence drug responses in patients. When aiming to obtain an optimal benefit-risk ratio of medicines and with the emergence of genotyping technology, pharmacogenetic studies are important for providing recommendations on drug treatments. Advances in electronic healthcare information systems can contribute to increasing the quality and efficiency of such studies. This review describes the definition of pharmacogenetics, gene selection and study design for pharmacogenetic research. It also summarizes the potential of linking pharmacoepidemiology and pharmacogenetics (along with its strengths and limitations) and provides examples of pharmacogenetic studies utilizing electronic health record databases. © 2014 The Association for the Publication of the Journal of Internal Medicine.
    Original languageEnglish
    Pages (from-to)590-604
    Number of pages14
    JournalJournal of Internal Medicine
    Volume275
    Issue number6
    DOIs
    Publication statusPublished - 2014

    Keywords

    • Electronic health records
    • Pharmacogenetics

    Fingerprint

    Dive into the research topics of 'Application of routine electronic health record databases for pharmacogenetic research'. Together they form a unique fingerprint.

    Cite this